NCT00237393 - Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

December 31, 2007

Conditions

PTSD

Interventions

DRUG

Quetiapine

Dosage initiated at 25 mg HS with gradual titration to target dose of 400 mg HS, up to maximum of 800 mg HS.

DRUG

Placebo

Dosage initiated at 25 mg HS with gradual titration to target dose of 400 mg HS, up to maximum of 800 mg HS.

Trial Locations (2)

Ralph H. Johnson VAMC, Charleston

NM VA Healthcare System, Albuquerque